Wednesday, December 13, 2017 12:14:02 PM
Dec 12, 2017 @ 10:07 AM 1,808
Marijuana Is The Next Big Investment, But Here's Why Most Investors Will Have To Wait
Duncan Rolph , Contributor
I cover all things investment. Insight with a twist.
Opinions expressed by Forbes Contributors are their own.
Photographer: Stefan Wermuth/Bloomberg
California is one the latest states to legalize recreational marijuana. With Proposition 64 going into full effect on Jan. 1, 2018, we could be one step closer to new federal regulations, which would make investment opportunities in the marijuana industry more accessible to everyone.
Cannabis-related businesses constitute one of the fastest growing industries in the United States. The medical marijuana market alone was worth $4.7 billion in 2016 and is expected to grow to $13.3 billion by 2020. Meanwhile, adult recreational sales amounted to $2.6 billion in 2016 and could reach $11.2 billion by 2020. With promising revenue and expansion across states, industries and product offerings, the marijuana industry has become an attractive opportunity for investors.
But until now, investor participation in the legal cannabis market has been relatively small. Will that change? And, if so, how can investors get in on the ground floor?
Limited Opportunities in the Past
Silicon Valley has been funneling capital into the cannabis industry since the early stages of the legalization process, but this space remains closed to the average investor. The only way for individual investors to take advantage of the industry's 16 percent projected annual growth rate is to make a direct investment in a marijuana business or to join a syndicate group as a limited partner. However, this approach is not a viable option for most investors due to the amount of capital required, access to deals, and illiquidity.
New Frontier Analytics
Marijuana Annual Growth Rate
Recommended by Forbes
Even indirect exposure via pharmaceutical and medical research companies is extremely limited, unless you have millions to invest like PayPal co-founder Peter Thiel, who recently invested in the Seattle-based private equity firm Privateer Holdings, which funds marijuana-related medical research and products.
The main obstacle to investing in cannabis comes from federal regulations. Even though 29 states currently have some form of legally permissible medical or recreational marijuana use, pot is still a Schedule I regulated substance in the eyes of the federal government.
Current federal regulations mean that companies involved in the marijuana space cannot go public. The SEC requires companies to meet some strict standards before they can be traded on the stock market, so any kind of involvement with the cannabis industry could run afoul federal laws. Publicly-traded pharmaceutical and biotech companies deliberately stay away from the cannabis industry for this very reason.
Page 1 / 2 Continue
Website Feedback
News Tip
Report Corrections
Reprints & Permissions
Recent KAYS News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/15/2024 09:38:31 PM
- Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health • InvestorsHub NewsWire • 11/28/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:25:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:15:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 11:48:09 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:15:57 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 12:44:25 PM
- Kaya Holdings, Inc.'s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A. • InvestorsHub NewsWire • 05/24/2023 01:48:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM